AFC -2018 -Mtg -06 1
th


G avi Alliance Audit and Finance Committee Meeting
12 October 2018
Gavi Office, Washington DC, USA


1. Chair?s report

1.1 Finding a quorum of Audit and Finance Committee (AFC) members present, the
meeting commenced at 08. 05 Washington DC time on 12 October 201 8. David
Sidwell, AFC Chair, chaired the meeting .

1.2 The Chair noted the Executive Session held by the Committee on 11 October.

1.3 Standing declarations of interest were tabled to the Committee (Doc 01a in the
Committee pack) alongside t he minutes of its meeting on 26 July 2018, including
the commercially sensitive minutes (Doc 01b). The Committee also reviewed its
action sheet (Doc 01c).

1.4 Anthony Brown , Senior Legal Counsel , provided an update to the Committee on
the action item relating to cyber insurance coverage from the Committee meeting
of 4 June 2018. Mr Brown explained that the Secretariat had since met with the
insurance broker and confirmed coverage on all major elements relating to cyber
insurance.

1.5 It was however noted that some gaps had been identified for which additional costs
of between US$ 10,000 -15,000 may be applied for coverage . Mr Brown stated that
Gavi?s main risks from cyber -crime would be data theft or data breach but not
financial loss .

1.6 Finally Mr Brown explained that the Secretariat is looking to put in place a cyber -
security policy to cover these gaps and will consult with the insurance broker on
appropriate furthe r analysis . The Secretariat committed to updat ing the AFC on
any modified coverage at the next insurance update.

Discussion

? In response to a question from a Committee member , t he Secretariat confirm ed
that currently control assessments are not required to validate a cyber insurance
claim. It was clarified that there may be some requirements if a stand -alone cyber -
security policy is pursued but that the relevant analysis would be undertaken
before taking o ut any new policies.

? The Chair noted the positive steps taken by the Secretariat an d ask ed that the
insurance item be discussed on a regular basis by the Committee .

------


Minutes

Gov -2018 -Mtg -05 1




G avi Alliance Governance Committee Meeting
10 October 2018
Global Health Campus , Geneva , Switzerland


1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 11.02 local
time on 10 October 2018 . Mr Bill Roedy, Board Vice Chair and Governance
Committee Chair, chaired the meeting .

1.2 The Chair welcomed all participants and in particular Minister Amir Aman Hagos,
who was attending a Governance Committee meeting for the first time. He also
expressed appreciation to those joining the meeting by phone from locations
where the time zones pr esented challenges.

1.3 Standing declarations of interest were tabled to the Committee (Doc 01a in the
Committee pack).

1.4 The Committee noted the minutes of its meeting on 4 June 2 018 (Doc 01b) which
had been approved by no -objection on 9 July 2018 .

1.5 The Committee noted its action sheet ( Doc 01c ) and forward workplan (Doc 01d).

-----

2. Nominations

2a. Board/Committee member nominations

2a.1 Philip Armstrong, Director, Governance and Secretary to the Board, presented this
item (Doc 02a), highlighting issues specific to the Board and some of the Board
Committees, as well as concerns raised in particular by the Board Chair and the
Chair of the Audit and Finance Committee.

2a.2 In the context of the nominations submitted for Governance Committee
consideration, attention was drawn in particular to the submission from the
Research and Technical Health Institutes (R&THI) constituency which had
submitted three candidates for one seat and requested the Governance
Committee to make its selection based o n submitted information.

Discussion

? Committee members noted that a number of constituencies had requested an
extension to November in submitting nominations for consideration.


Minutes

Launched at Davos in 2016, Innovation for Uptake, Scale and Equity in Immunisation (INFUSE) seeks tried and tested innovations that have potential to improve vaccine delivery. It then “infuses” them with capital and expertise to help take them to scale.